Offerings // HARVARD BIOSCIENCE INC

HBIO offering history

Every offering-related filing in HARVARD BIOSCIENCE INC’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,001 filings back to Nov 19, 2007.

Last executed offering
None found
in filings back to Nov 19, 2007
Last registration (announced)
Jan 30, 2026
S-3 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Feb 9, 2026424B3UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 9, 2026EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jan 30, 2026S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 27, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Dec 6, 2024S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 9, 2018EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Apr 30, 2018S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Apr 30, 2015EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Apr 27, 2015S-3/AREGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Apr 21, 2015S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
HBIO offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full HBIO workspace →
HBIO offering FAQ

When did HBIO last execute an offering?

No executed-offering document (424B pricing supplement or 8-K item 3.02) appears in the 1001 filings EDGAR returns for HARVARD BIOSCIENCE INC, reviewed back to 2007-11-19.

When did HBIO last announce or register an offering?

The most recent registration is a S-3 filed 2026-01-30. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.